TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION

TARGET LEVELS OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM COMPONENTS AND THEIR ROLE IN CARDIOVASCULAR EVENT DEVELOPMENT AMONG PATIENTS WITH ARTERIAL HYPERTENSION

The aim of this study was to identify the optimal, characterised by minimal risk of cardiovascular events (CVE), levels of renin-angiotensin-aldosterone system (RAAS) components in patients with arterial hypertension (AH). In total, 454 patients with high-risk AH were examined (age 18-65 years; 92 m...

Full description

Bibliographic Details
Main Authors:	Sh. V. Akhadov, G. R. Ruzbanova, G. S. Molchanova, T. G. Talalaeva, S. N. Khoreva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-06-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension plasma renin activity plasma aldosterone concentration myocardial infarction stroke
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1350

Similar Items

SYMPATHO-ADRENAL SYSTEM IN ARTERIAL HYPERTENSION PATIENTS: ACTIVITY ASSESSMENT AND CLINICAL VALUE
by: Sh. V. Akhadov, et al.
Published: (2009-04-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2010-06-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
by: S. V. Akhadov, et al.
Published: (2016-01-01)

Diagnostic Role of Captopril Challenge Test in Korean Subjects with High Aldosterone-to-Renin Ratios
by: Jung Hee Kim, et al.
Published: (2016-06-01)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
by: Fabio Bioletto, et al.
Published: (2023-05-01)

Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA)
by: Chia-Hung Lin, et al.
Published: (2024-03-01)

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study
by: Jinbo Hu, et al.
Published: (2021-12-01)

Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
by: Preaw Suwannasrisuk, et al.
Published: (2020-04-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

The state of renin-aldosterone system in patients with resistant arterial hypertension
by: О. H. Оbertynska
Published: (2019-06-01)

Survey of renin and aldosterone testing practices by Ontario laboratories – Providing insight into best practices
by: Angela C. Rutledge, et al.
Published: (2021-05-01)

Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension
by: G M Dadashova
Published: (2015-09-01)

Low plasma renin activity is associated with “Apparently” idiopathic atrial fibrillation
by: Youmei Shen, et al.
Published: (2023-12-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
by: Katy Satué, et al.
Published: (2017-06-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
by: Fei Qin, et al.
Published: (2022-01-01)

Diet‐induced prediabetes: Effects on the activity of the renin–angiotensin–aldosterone system in selected organs
by: Bongeka Cassandra Mkhize, et al.
Published: (2022-05-01)

Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study
by: Giuseppe Maiolino, et al.
Published: (2017-05-01)

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism
by: Chung-Yi Cheng, et al.
Published: (2021-12-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Role of renin–angiotensin aldosterone system on short-term blood pressure variability in hypertensive patients
by: Minako Inoue, et al.
Published: (2018-10-01)

Regulation of human salt-sensitivite hypertension by myeloid cell renin-angiotensin-aldosterone system
by: Lale A. Ertuglu, et al.
Published: (2023-07-01)

Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis
by: Chin-Chen Chang, et al.
Published: (2021-01-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

The activity of the renin-angiotensin-aldosterone system before and after parathyroidectomy in patients with primary hyperparathyroidism
by: Liubov G. Yanevskaya, et al.
Published: (2021-12-01)

The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
by: Rawan M. Alnazer, et al.
Published: (2021-02-01)

Low renin hypertension
by: Manisha Sahay, et al.
Published: (2012-01-01)

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
by: Gregory P. Veldhuizen, et al.
Published: (2021-02-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
by: N.D. Filipets, et al.
Published: (2019-02-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)